Premium
Combined IL‐6 and JAK/STAT inhibition therapy in COVID‐19‐related sHLH, potential game changer
Author(s) -
Portsmore Sophie,
Tran Nguyen Thien Ngoc,
Beacham Emma,
Neelakantan Pratap
Publication year - 2020
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.16966
Subject(s) - tocilizumab , medicine , cytokine storm , ruxolitinib , janus kinase , immunology , context (archaeology) , macrophage activation syndrome , inflammation , cytokine , disease , covid-19 , infectious disease (medical specialty) , bone marrow , biology , paleontology , myelofibrosis
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom